Brain Activity During Complex Walking in People With Atypical Parkinsonian Syndromes
NCT ID: NCT06906276
Last Updated: 2025-07-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
30 participants
OBSERVATIONAL
2025-03-14
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The challenge of improving treatments of motor-cognitive difficulties (such as dual-tasking and navigation) is daunting, and an important step is arriving at a method that accurately portrays these impairments in an ecologically valid state. The investigators aim therefore to explore brain function during complex walking in healthy and APD by investigating the effects of age and neurological disease on motor-cognitive performance and its neural correlates during three conditions of complex walking (dual-task walking, navigation and a combination of both) using non-invasive measures of brain activity (functional near infrared spectrometry, fNIRS) and advanced gait analysis in real time in older healthy adults and people with APD.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Walking and Thinking - Brain Activity During Complex Walking in Aging and Parkinson's Disease
NCT05218213
Identification of Motor Symptoms Related to Parkinson's Disease Using Motion Tracking Sensors at Home
NCT03366558
Brain Activity During Gait in Parkinson's
NCT04863560
Movement Improves Brain Health and Cognition in Parkinson's Disease
NCT07299279
The Effects of 24-Weeks Community-based Brisk Walking in People With Parkinson's Disease
NCT06707402
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Atypical Parkinsonian syndromes
-People with either Progressive supranuclear palsy or Multiple system atrophy
Assessment of brain activity with fNIRS and behavioural assessments (motor, motor-cognitive and cognitive) during three complex walking conditions.
Dual-task walking with the auditory stroop task. Navigational walking - a course consisting of a distribution of 45 and 90 degrees turns to the left and right Navigational and dual-task walking (condition 1 and 2 together)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Assessment of brain activity with fNIRS and behavioural assessments (motor, motor-cognitive and cognitive) during three complex walking conditions.
Dual-task walking with the auditory stroop task. Navigational walking - a course consisting of a distribution of 45 and 90 degrees turns to the left and right Navigational and dual-task walking (condition 1 and 2 together)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* MSA according to MDS criteria (2022)
* the ability to walk with or without a mobility device for ≤5 minutes continuously
Exclusion Criteria
* severe freezing of gait
* Severe hearing or visual impairments that affect participation in the assessments
* Other neurological diseases
* Other diseases that can affect gait or balance.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Karolinska University Hospital
OTHER
Karolinska Institutet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Erika Franzén
Professor Erika Franzén, RPT, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Franziska Albrecht, PhD
Role: PRINCIPAL_INVESTIGATOR
Karolinska Institutet
Erika Franzén, Prof,
Role: PRINCIPAL_INVESTIGATOR
Karolinska Institutet
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Karolinska Institutet
Solna, Solna, Sweden
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-03059
Identifier Type: OTHER
Identifier Source: secondary_id
4-2452/2024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.